Company Filing History:
1 out of 38 
1 out of 6 
1 out of 8 Years Active: 2019
Title: Roger Estrada Tejedor: Innovator in Myotonic Dystrophy Treatment
Introduction
Roger Estrada Tejedor is a notable inventor based in Barcelona, Spain. He has made significant contributions to the field of medical research, particularly in the treatment of myotonic dystrophy. His innovative work has led to the development of a unique compound aimed at addressing this challenging condition.
Latest Patents
Roger Estrada Tejedor holds a patent for "Compounds for the treatment of myotonic dystrophy." This invention relates to a compound of formula (I), provided that this compound is not caffeine, for use in the treatment of myotonic dystrophy type 1 and type 2. The patent also encompasses compositions comprising the compound of formula (I) and introduces new compounds that are dimers of compounds of formula (I). He has 1 patent to his name.
Career Highlights
Throughout his career, Roger has worked with esteemed institutions such as Universitat de València and Institut Químic de Sarria CETS Fundació Privada. His work in these organizations has allowed him to advance his research and contribute to the scientific community.
Collaborations
Roger has collaborated with notable colleagues, including Ruben Artero Allepuz and Josep Castells Boliart. These partnerships have enriched his research and fostered innovation in his field.
Conclusion
Roger Estrada Tejedor is a dedicated inventor whose work in developing treatments for myotonic dystrophy showcases his commitment to advancing medical science. His contributions are significant and reflect the importance of innovation in healthcare.